https://www.cidrap.umn.edu/covid-19/...-study-reveals
During pandemic, ivermectin use rose 10-fold, hydroxychloroquine use doubled, study reveals
...
Announcement
Collapse
No announcement yet.
Search Result
Collapse
272 results in 0.0543 seconds.
Keywords
Members
Tags
-
Lance started a topic CIDRAP- During pandemic, ivermectin use rose 10-fold, hydroxychloroquine use doubled, study revealsin CIDRAPCIDRAP- During pandemic, ivermectin use rose 10-fold, hydroxychloroquine use doubled, study reveals
-
tetano started a topic J Med Virol . Systematic Reevaluation of Repurposed Drugs Against the Main Protease of SARS-CoV-2 via Combined Experimentsin TreatmentsJ Med Virol . Systematic Reevaluation of Repurposed Drugs Against the Main Protease of SARS-CoV-2 via Combined Experiments
J Med Virol
. 2025 Feb;97(2):e70229.
doi: 10.1002/jmv.70229. Systematic Reevaluation of Repurposed Drugs Against the Main Protease of SARS-CoV-2 via Combined Experiments
Jiankai Ye 1 , Rui Zhang 1 , Jiahao Zh...
-
tetano started a topic Int Arch Otorhinolaryngol . Treatments for Olfactory Dysfunction in COVID-19: A Systematic Reviewin TreatmentsInt Arch Otorhinolaryngol . Treatments for Olfactory Dysfunction in COVID-19: A Systematic Review
Int Arch Otorhinolaryngol
. 2024 May 25;28(4):e728-e743.
doi: 10.1055/s-0044-1786046. eCollection 2024 Oct. Treatments for Olfactory Dysfunction in COVID-19: A Systematic Review
Esmaeil Mehraeen 1 , Soudabeh Y...
-
tetano started a topic Am J Emerg Med . Antiviral therapy for COVID-19 virus: A narrative review and bibliometric analysisin TreatmentsAm J Emerg Med . Antiviral therapy for COVID-19 virus: A narrative review and bibliometric analysis
Am J Emerg Med
. 2024 Sep 4:85:98-107.
doi: 10.1016/j.ajem.2024.09.001. Online ahead of print. Antiviral therapy for COVID-19 virus: A narrative review and bibliometric analysis
Saeid Mezail Mawazi 1 , Nousheen...
-
tetano started a topic BMC Infect Dis . Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trialin TreatmentsBMC Infect Dis . Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trial
BMC Infect Dis
. 2024 Jul 22;24(1):719.
doi: 10.1186/s12879-024-09563-y. Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical...
-
CIDRAP- Study: US children at times received ineffective COVID-19 treatments
https://www.cidrap.umn.edu/covid-19/...-19-treatments
Study: US children at times received ineffective COVID-19 treatments
Stephanie Soucheray, MA
Today...
-
UGANDA/SOUTH SUDAN: Nodding Syndrome - Hundreds of children infected
UGANDA: Nodding disease or "river epilepsy"?
KITGUM, 10 August 2009 (IRIN) - A rare and unexplained brain disease has affected hundreds of Ugandan children, health workers say.
The "nodding disease"...
-
tetano started a topic Clin Infect Dis . Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019in TreatmentsClin Infect Dis . Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019
Clin Infect Dis
. 2024 May 1:ciae159.
doi: 10.1093/cid/ciae159. Online ahead of print. Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled...
-
CIDRAP- NEWS BRIEFS March 4, 2024
https://www.cidrap.umn.edu/all-news
US measles cases rise to 41
News brief
Today at 3:49 p.m.
Lisa Schnirring
Topics
Measles
Since its last update on February 23, the...
-
Sci Rep . Binding behavior of receptor binding domain of the SARS-CoV-2 virus and ivermectin
Sci Rep
. 2024 Feb 2;14(1):2743.
doi: 10.1038/s41598-024-53086-0. Binding behavior of receptor binding domain of the SARS-CoV-2 virus and ivermectin
Kasidy R Gossen # 1 , Meiyi Zhang # 1 , Zivko L Nikolov 1 ,...
-
tetano started a topic PLoS One . Real-world prescription of anti-COVID-19 drugs in hospitalized patients with COVID-19 in Japanin TreatmentsPLoS One . Real-world prescription of anti-COVID-19 drugs in hospitalized patients with COVID-19 in Japan
PLoS One
. 2024 Jan 26;19(1):e0297679.
doi: 10.1371/journal.pone.0297679. eCollection 2024. Real-world prescription of anti-COVID-19 drugs in hospitalized patients with COVID-19 in Japan
Haruka Shida 1 , Maki ...
-
tetano started a topic J Infect Chemother . Efficacy and safety of ivermectin in patients with mild COVID-19 in Japan and Thailandin TreatmentsJ Infect Chemother . Efficacy and safety of ivermectin in patients with mild COVID-19 in Japan and Thailand
J Infect Chemother
. 2023 Dec 26:S1341-321X(23)00316-1.
doi: 10.1016/j.jiac.2023.12.012. Online ahead of print. Efficacy and safety of ivermectin in patients with mild COVID-19 in Japan and Thailand
Hiroshige M...
-
tetano started a topic J Clin Transl Sci . ACTIV-6: Operationalizing a decentralized, outpatient randomized platform trial to evaluate efficacy of repurposed medicines for COVID-19in TreatmentsJ Clin Transl Sci . ACTIV-6: Operationalizing a decentralized, outpatient randomized platform trial to evaluate efficacy of repurposed medicines for COVID-19
J Clin Transl Sci
. 2023 Oct 31;7(1):e221.
doi: 10.1017/cts.2023.644. eCollection 2023.
ACTIV-6: Operationalizing a decentralized, outpatient randomized platform trial to evaluate efficacy of repurposed medicines for ...
-
CIDRAP- NEWS BRIEFS November 17, 2023
https://www.cidrap.umn.edu/all-news
Study shows modest flu vaccine protection against serious disease in kids last season
News brief
42 minutes ago.
Stephanie Soucheray, MA
Topics
...
-
WHO updates guidelines on treatments for COVID-19. 10 November 2023
10 November 2023
Statement
Geneva, Switzerland
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated...